Formulation

The company focuses on the research and development of oral solid formulations, focusing on the R&D of new drugs, generic drugs and secondary developed products for marketing. Formulation R&D services include pre-formulation research, formulation research, and process research. At present, the company can develop the formulation of ordinary tablets, dispersive tablets, oral disintegrating tablets, bilayer tablets, skeleton sustained-release tablets and osmotic pump tablets. We are proficient in writing the application data of formulation research according to ICH M4 application requirements.